Rep. Sherrill Calls for $10 Billion Investment in Biomedical Research

Washington, DC -- Representative Mikie Sherrill (NJ-11) introduced the Biomedical Innovation Expansion Act of 2019 this afternoon with Representatives Mike Levin (CA-49) and Abigail Spanberger (VA-07) to invest $10 billion over the next ten years in the National Institutes of Health (NIH) to provide support for scientific research related to antibiotic resistance and rare diseases.

The Biomedical Innovation Expansion Act of 2019 also provides steady, predictable resources through the NIH Innovation Fund, which was created through the bipartisan 21st Century Cures Act in 2016, and increases support for all current NIH Innovation Fund activities to 2030.

“For generations, New Jersey has been a world leader in biomedical research innovation,” said Representative Sherrill. “I’ve seen the exciting and breakthrough research happening right here in North Jersey that will help us save lives, improve health, and offer hope to people affected by rare diseases. This bill continues the momentum of support for biomedical research funding to ensure America remains a leader in research innovation and that we support jobs in New Jersey.”

Full release here: Rep. Sherrill Calls for $10 Billion Investment in Biomedical Research